₹ (%)
- NSE
- BSE
Overview
- BSE Code 539730
- NSE Symbol
- ISIN Demat INE194R01017
- Book Value (₹) 299.47
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 433.92
- P/E (TTM) 20.85
- EPS (TTM) 44.07
- Div Yield (%) 0.08
Performance
Corporate Actions
No Data Found
About Fredun Pharmaceuticals Ltd
Incorported in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially created and deployed D N Pharma, a proprietory firm, for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL.
FPL was created and deployed with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then created and deployed a formulation unit at Palghar (Thane district), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.
In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden.
Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.
Founded | : 1987 |
Chairman | : Daulat N Medhora |
Managing Director | : Daulat N Medhora |
Address | : 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031, |
HO Tel | : 91 22 4031 8111 |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)